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ABSTRACT 
 
Background: CogState is a computerized cognitive battery spanning domains of memory, executive 
function, and speed and processing. CogState, designed to be robust to education level and efficient 
for repeated administration with minimal practice effects, holds potential for detecting early 
cognitive dysfunction in at-risk populations. This project aimed to provide convergent and construct 
validity for aspects of the CogState battery in a late-middle-aged cohort enriched for risk factors for 
Alzheimer’s disease (AD) and to evaluate CogState performance against traditional 
neuropsychological tests of delayed memory.  
 
Methods: 469 late-middle-aged participants from the Wisconsin Registry for Alzheimer’s 
Prevention (mean age 63.8±7 years at testing; 67% female; 39% APOE4+) completed a traditional 
paper-based neuropsychological battery and seven tests from the CogState battery approximately ten 
years post-baseline. A composite cognitive impairment index (CCII) was calculated using eight 
neuropsychological tests acquired longitudinally and estimated at age 65 to remove confounding 
effects of age. Early cognitive impairment status (n=70) was determined by consensus case review. 
A subset underwent cerebrospinal fluid (CSF) collection (n=73) and PET-PiB imaging (n=96). We 
examined relationships between CogState variables and demographic characteristics; relationships 
between CogState and scores on traditional paper-based neuropsychological tests as well as a 
composite cognitive impairment index; group differences between normal and cognitively impaired 
participants; and associations with previously acquired biomarkers for amyloid and tau (CSF total-
tau/Aβ42 and global PET-PiB burden) and neural injury (CSF neurofilament light protein). In 
parallel we examined three traditional tests of delayed memory with demographics, cognitive status, 
and biomarkers.  
 
Results: CogState variables were consistently related to age, but were relatively uncorrelated with 
other demographic variables examined. In contrast, traditional delayed memory tests were more 
highly influenced by demographic characteristics including sex, age, literacy, and education. With the 
exception of the One Back Test, CogState variables were statistically significantly related to most 
paper-based cognitive tests examined, and mapped onto the same cognitive domains. Cognitively 
impaired participants performed significantly worse compared to normal controls on all delayed 
memory and CogState tests except the One Back test. Greater CCII was associated with worse 
performance on all CogState tests. In this age range, cognitive performance on the CogState or 
delayed memory tests were not associated with biomarker levels with the exception of a mild 
relationship observed between One Card Learning test and CSF total-tau/Aβ42.  
 
Conclusions: CogState is related to several cognitive measures (individual paper-based 
neuropsychological test scores, cognitive impairment status, and CCII) but was only mildly 
associated with biomarker levels in late-middle-aged adults. The congruent cognitive results suggest 
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the CogState tests employed may have utility as non-circular outcomes, which are less influenced by 
demographic variability, in longitudinal studies of people at risk for AD. 
 
Key words: CogState, amyloid, cognitive impairment, preclinical Alzheimer’s disease 
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1 INTRODUCTION 
 
CogState is a computerized cognitive battery spanning domains of memory, executive function, and 
speed and processing. It has been shown to have acceptable stability and test-retest reliability with 
minimal practice effects at short test-retest intervals in groups of healthy controls and patients at 
various states of cognitive impairment and dementia (Hammers, et al., 2011; Lim, Jaeger, et al., 
2013).  CogState holds potential for detecting early cognitive dysfunction that may prove to be due 
to preclinical Alzheimer’s disease (AD).  
 
Previous studies have demonstrated differences between healthy controls, Mild Cognitive 
Impairment (MCI), and AD, with the most pronounced impairments in the latter two groups on 
CogState tests of learning and memory (Lim, et al., 2012; Maruff, et al., 2013). While some studies 
have found associations between CogState performance and biomarkers (Darby, et al., 2011; Lim, 
Ellis, et al., 2013; Lim, et al., 2014; Lim, Pietrzak, et al., 2015; Lim, Villemagne, et al., 2015; Mielke, et 
al., 2014; Thai, et al., 2015), other studies have failed to find such an association (Mielke, Machulda, 
Hagen, Christianson, et al., 2015; Mielke, et al., 2014). Thus far, there has been a primary focus on 
neuroimaging correlates of CogState, but there is a dearth of information on cerebrospinal fluid 
biomarkers.  
 
These analyses build on previous work investigating CogState as a tool for detecting AD at various 
stages of the dementia spectrum and seek to provide convergent and construct validity for CogState 
in detecting pre-dementia cognitive deficits during late-midlife. First we explored relationships 
between CogState variables and demographic characteristics. To assess convergent validity, we 
examined relationships between CogState and scores on traditional paper-based neuropsychological 
tests as well as a composite cognitive impairment index estimated at age 65, the average age at which 
CogState was administered. To assess construct validity, cognitively impaired and normal controls 
were compared on CogState performance. Additional construct validity for AD pathology was 
investigated by examining whether biomarkers for amyloid and tau (CSF total-tau/Aβ42 and global 
PET-PiB burden) and neural injury (CSF neurofilament light protein) predicted CogState 
performance approximately four years later. To evaluate benefits of CogState over traditional 
neuropsychological tests, we also examined relationships of three traditional tests of delayed 
memory with demographics, MCI status, and biomarkers.  
2 MATERIAL AND METHODS 
2.1 Participants 
 
The Wisconsin Registry for Alzheimer’s Prevention (WRAP) is a longitudinally followed cohort 
designed to identify biological and lifestyle risk factors associated with development of dementia due 
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to Alzheimer’s disease (Jonaitis, et al., 2013; Koscik, et al., 2014; Sager, Hermann, & La Rue, 2005). 
The WRAP study consists of 1,545 participants (mean age=53.6±6.6 years at first cognitive 
assessment), of which 72.4% have a parental family history of dementia due to Alzheimer’s disease. 
The CogState was instituted in 2014 and administered regardless of the WRAP visit number (3.2% 
of participants were administered the CogState at visit 2, 19.8% at visit 3, 24.5% at visit 4, and 52.5% 
at visit 5).  Participants were selected for these analyses if they had completed at least one of the 
tests in the CogState battery, which consists of seven tests. Additionally, some participants were 
previously recruited for biomarker substudies. The University of Wisconsin Institutional Review 
Board approved all study procedures.  
 
Of the 469 participants who had completed CogState, 10 met criteria for clinical MCI, another 60 
exhibited more subtle deficits (which we termed psychometric MCI), and 6 were classified as having 
a non-MCI related cognitive impairment. The clinical MCI and psychometric MCI participants are 
grouped together into a cognitively impaired group and the remaining 393 unimpaired participants 
are considered cognitively normal (Table 1).  
  
Table 1. Participant characteristics 
Demographic  Total 
Sample 
(N=469 
Cognitively 
Impaired 
(n=70) 
Cognitively 
Normal  
(n=393) 
p-value* 
Age at CogState (years) 64.81 (6.6) 66.26 (6.1) 63.39 (6.6) .001 
Sex (% female) 67.0% 57.1% 68.4% .064 
APOE4+ 39.0% 37.1% 38.7% .808 
Family History of AD 74.4% 67.1% 75.6% .137 
Education (years) 16.50 (2.6) 16.40 (2.9) 16.53 (2.6) .703 
WRAT reading standard score** 106.35 (9.2) 105.17 (11.2) 106.57 (8.8) .242 
WRAT reading raw score** 51.17 (4.4) 50.41 (5.4) 51.31 (4.2) .189 
Depression (CES-D) 6.21 (6.6) 6.30 (5.8) 5.93 (6.1) .634 
Computer familiarity (range 1-5) 4.74 (0.7) 4.56 (1.0) 4.77 (0.7) .097 
Values are Mean (SD) unless otherwise indicated. *P-value is for chi square or t-test comparing 
Cognitively Impaired and Cognitively Normal groups. **WRAT reading standard scores in addition 
to raw scores are reported for easier interpretation, but raw scores were used in all statistical models 
to main consistency with other variables which were not standardized for age and sex. 
APOE4=apolipoprotein E4 allele. WRAT=Wide Range Achievement Test. CES-D=Center for 
Epidemiological Studies Depression Scale.  
2.2 WRAP battery: CogState, paper-based neuropsychological testing, and demographic 
data collection 
 
CogState was administered on a laptop and included Continuous Paired Associate Learning (CPAL), 
Groton Maze timed chase test (GMCT), Groton Maze learning test (GML), Groton Maze learning 
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test delayed recall (GMR), One-card learning (OCL), One-back memory (ONB), and Two-back 
memory (TWOB). CPAL tests delayed visual memory through paired associate learning, GMCT 
tests speed of visual processing, GML tests executive function, GMR tests delayed recall, and OCL, 
ONB, and TWOB are tests of working memory. For CPAL, GML, and GMR, total number of 
errors were assed; for GMCT moves per second was assessed; and for the three card tasks (OCL, 
ONB, and TWOB) accuracy was assessed using the arcsine proportion to correct for normality. 
Data were only included that passed criteria for completion and integrity. To be considered 
“complete,” at least 75% of all responses needed to be observed for the card tasks (OCL, ONB, 
TWOB), all 28 steps of the maze path needed to be completed for the Groton Maze tasks (GML, 
GMR), and all rounds needed to be completed for CPAL; there is no completion check for GMCT. 
Integrity checks were completed for the three card tasks only and were satisfied if the proportion 
correct was above chance (at least 50% correct). Not all participants completed the full CogState 
battery, with more incomplete data for tests administered at the end of the battery. Missing data and 
completion and integrity checks are summarized in Supplementary Table 1. 
 
A comprehensive neuropsychological battery is performed at each WRAP visit. For this analysis, 
tests were selected that were primarily related to memory or executive function and included Rey 
Auditory Verbal Learning Test (RAVLT) total trials 1-5 and delayed recall; Wechsler Memory Scale-
Revised (WMS-R) Logical Memory immediate and delayed recall; Brief Visuospatial Memory Test 
(BVMT) immediate and delayed recall; Boston Naming Test; Animal Naming; CFL fluency; Stroop 
color-word interference trial; Trail Making Test (TMT) Parts A and B; Wechsler Adult Intelligence 
Scale-Revised (WAIS-R) Digit Symbol, Letter Number, Digit Span forward, and Digit Span 
backward; and Mini Mental State Examination (MMSE). 
 
A composite cognitive impairment index (CCII) was calculated using a set of eight cognitive 
measures: Trails A and B, WAIS Digit Span forward and backward, RAVLT total trials 1-5, RAVLT 
delayed recall, Boston Naming, and MMSE. Visits were excluded when fewer than four of these 
measurements were available. We applied the progression score model (Bilgel, Jedynak, Wong, 
Resnick, & Prince, 2015; Jedynak, et al., 2012) to align individuals along a linear cognitive trajectory 
based on their longitudinal cognitive measure profiles, adjusting for inter-individual differences in 
rates of change. The composite cognitive impairment index computed using this method is an 
individualized summary of the eight cognitive measures, with higher values indicating lower 
cognitive performance in all measures. Different from previous approaches, we accounted for 
correlations among cognitive measures and constrained the CCII scores to increase linearly with age 
within each individual. To remove confounding effects of age at entry into WRAP, a composite was 
estimated at age 65 based on an approximate expression for the time derivative of the CCII.  
 
Supplementary Table 1. Completion, integrity, and missing data 
CogState Test  Completion Check Integrity Check Data missing 
CPAL  n=2 incomplete N/A n=3 missing 
GMCT  N/A N/A n=0 missing 
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GML  n=0 incomplete N/A n=0 missing 
GMR  n=3 incomplete N/A n=6 missing 
OCL  n=0 incomplete n=7 below level of chance n=1 missing 
ONB  n=0 incomplete n=12 below level of chance n=2 missing 
TWOB  n=0 incomplete n=2 below level of chance n=4 missing 
CPAL= Continuous Paired Associate Learning (CPAL); GMCT=Groton Maze timed chase test; 
GML= Groton Maze learning test; GMR=Groton Maze learning test delayed recall; OCL=One-
card learning; ONB=One-back memory; TWOB=Two-back memory.  
 
2.3 Biomarker collection 
2.3.1 PET-PiB 
 
Detailed methods for [C-11] PiB radiochemical synthesis, PiB-PET scanning, and distribution 
volume ratio map generation using the cerebellum as a reference region have been described 
previously (Johnson, et al., 2013). PiB-PET images were registered to a T1-weighted anatomical scan 
collected on a GE 3.0 Tesla MR750 (Waukesha, WI) using an 8 channel head coil (Berman, et al., 
2015; Johnson, et al., 2013; Annie M. Racine, et al., 2014). A composite measurement of global 
amyloid derived from eight bilateral ROIs (angular gyrus, anterior cingulate gyrus, posterior cingulate 
gyrus, frontal medial orbital gyrus, precuneus, supramarginal gyrus, middle temporal gyrus, and 
superior temporal gyrus) was calculated as described previously (Racine, et al., 2016; Sprecher, et al., 
2015). N=91 participants underwent PiB-PET imaging approximately 4.1 years prior to CogState.  
2.3.2 Cerebrospinal fluid  
 
CSF was collected as described previously (Almeida, et al., 2015; Starks, et al., 2015). CSF Aβ42 and 
total-tau (t-tau) were quantified with sandwich ELISAs (INNOTEST β-amyloid1-42, hTAU-Ag, 
respectively; Fujirebio Europe, Ghent, Belgium). CSF t-tau/Aβ42 was calculated by dividing CSF t-
tau by CSF Aβ42.  CSF neurofilament light protein (NFL) was measured with a sandwich ELISA 
method as described by the manufacturer (NF-light ELISA kit, UmanDiagnostics AB, Umeå, 
Sweden). N=70 participants underwent baseline lumbar puncture approximately 3.7 years prior to 
Cogstate. 
 
CSF assays were performed in two batches. A subset of CSF samples (n=73 from the entire CSF 
database, not just from individuals who had also undergone CogState testing) was assayed in both 
batches so that reliability tests could be performed. Intraclass correlation coefficients (ICCs) for 
absolute agreement were high between batches for CSF t-tau/Aβ42 (ICC=.978) and NFL (.975) so 
batches were combined to obtain the maximal sample size, but interpretation of these variables 
should keep this limitation in mind.  
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2.4 Statistical analyses 
2.4.1 Associations of CogState with demographics and traditional neuropsychological tests 
 
For dichotomous characteristics (sex, parental family history of AD, and APOE4), t-tests were 
performed on the seven CogState variables. For continuous variables (total years of education; 
literacy as measured by baseline Wide Range Achievement Test reading raw score; age at testing; and 
depression as measured by the Center for Epidemiologic Studies Depression Scale), we performed 
Pearson correlations. For ordinal variables (computer familiarity as measured on a Cognitive 
Activities questionnaire) Spearman’s rank-order correlations were performed. Relationships between 
traditional paper-based neuropsychological tests and CogState tests were evaluated with Pearson 
correlations. Cohen’s d were calculated for t-tests and effect sizes of .2, .5., and .8 are interpreted as 
small, medium, and large, respectively. Correlation coefficients of .1, .3., and .5 are interpreted as 
small, medium, and large effect sizes, respectively (J. Cohen, 1992). Significance was inferred at a 
Bonferroni-corrected p-value for seven CogState tests (p<.05/7=.007) 
 
Because we were interested in comparing performance of the CogState compared to traditional 
paper-based tests, we also examined correlations between demographics and select traditional 
neuropsychological tests. Numerous studies have identified delayed episodic memory as one of the 
earliest cognitive domains to become impaired in AD (Backman, Jones, Berger, Laukka, & Small, 
2005; Salmon & Bondi, 2009; Weintraub, Wicklund, & Salmon, 2012), likely during the preclinical 
timeframe; therefore, to reduce the number of multiple comparisons, we selected three tests of 
delayed memory from our neuropsychological battery: RAVLT delayed, Logical Memory delayed, 
and BVMT delayed. Although there were only three delayed recall tests, we still evaluated 
significance at the threshold of p<.007. 
  
2.4.2 ANCOVA comparing normal controls and participants with MCI 
 
Cognitively impaired participants were compared to cognitively normal controls by ANCOVA 
controlling for age, literacy, sex, APOE4, family history of AD, and computer familiarity. 
Significance is inferred at p<.007 (Bonferroni-corrected p-value for seven CogState tests). Effect 
sizes by partial eta squared are reported. Small, medium, and large effect sizes for eta squared are .01, 
.06, and .14, respectively (Jacob Cohen, 1988). 
 
We also compared cognitive groups on the select traditional neuropsychological tests identified in 
section 2.4.1.. However, it should be noted that performance on these tests were evaluated during 
consensus, particularly for determining whether MCI was an amnestic or non-amnestic variant; 
therefore, cognitive status and delayed recall scores are not unrelated. Thus, direct comparison of 
effect sizes for CogState and delayed recall tests by cognitive group is not possible.  
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2.4.3 Composite cognitive impairment index regression 
 
In addition to examining individual neuropsychological tests, we investigated CCII, which takes 
advantage of longitudinally measured cognition, is associated with performance on CogState. We ran 
regression analysis with CogState as the dependent variable and CCII as the independent variable of 
interest, controlling for age at CogState testing, literacy, sex, APOE4, family history of AD, and 
computer familiarity. Significance was inferred at p<.007 (Bonferroni-corrected p-value for seven 
CogState tests). Variance inflation factors (VIF) and tolerance were assessed and deemed normal if 
tolerance is greater than .1 and VIF is less than 10. Cohen’s f 2 for hierarchical regression, R2, and R2-
change (the change in R2 after adding CCII to the model) are reported. Cohen’s f2 of 0.02, 0.15, and 
0.35 are considered small, medium, and large, respectively (Jacob Cohen, 1988). RAVLT delayed was 
included in the making of CCII so we only evaluated the relationships between Logical Memory 
delayed and BVMT delayed and CCII.  
 
2.4.4 Biomarker associations 
 
2.4.4.1. Biomarker normalization and dichotomization  
 
To improve normality, CSF t-tau/Aβ42 and NFL were transformed using the natural log. Although 
PiB burden was skewed to the right, traditional transformations were ineffective at improving 
normality. Instead, we chose to examine PiB burden untransformed (with and without an outlier) as 
a continuous variable and as a dichotomous variable with the goal of capturing the hypothesized 
underlying binomial distribution.  
 
A cut-off value for PiB positivity was determined using receiver operating characteristic (ROC) 
analysis in pROC R Statistical Package (Robin, et al., 2011) bootstrapping 2000 times with 
replacement and stratification of sample. We used expert visual ratings of PiB positive or negative 
that have been described previously as the diagnostic groups (Johnson, et al., 2013; A. M. Racine, et 
al., 2014). Supplementary Figure 1 depicts the ROC plot with an area under the curve of .974. A 
threshold was determined using Youden’s Index which identifies the PiB burden value that 
maximizes both sensitivity and specificity (Youden, 1950). A threshold of 1.19 was identified which 
corresponded to sensitivity of .938 and specificity of .917.  
 
2.4.4.2. Associations between biomarkers and CogState  
 
First, we performed Pearson correlations between CogState variables and three biomarkers of 
interest: CSF t-tau/Aβ42, CSF NFL, and global PiB burden. T-tests were performed to compare 
CogState performance between PiB+ and PiB- groups. Second, to investigate whether biomarkers 
are predictive of CogState performance, we ran multiple regressions with CogState scores as the 
dependent variable and biomarker as the independent variable of interest for biomarkers with 
significant or trending correlations with CogState. Comparable models with ANCOVA were 
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performed for PiB positivity. In addition to the covariates used in the CCII regression models, we 
additionally controlled for the interval from biomarker collection to CogState testing (CSF to 
CogState 44.3±13.5 months; PET-PiB to CogState 49.6±7.9 months). VIF and tolerance were again 
inspected.  
 
We also analyzed the relationship between traditional neuropsychological tests and biomarkers using 
the same tests of delayed memory as section 2.4.3. and the same models as described for the 
CogState variables. Because we expected the relationship between cognitive performance and 
biomarkers to be mild, we evaluated significance at a more mild threshold of p<.05 for both 
CogState and delayed memory tests. 
3 RESULTS 
3.1 Associations of CogState with demographics and traditional neuropsychological tests 
 
Participant characteristics are summarized in Table 1. Cognitively impaired and cognitively normal 
groups only differed on age at CogSate testing with the cognitively impaired group being slightly 
older (by about three years).  
 
CogState scores did not differ significantly by APOE4 status or family history. CPAL (p<.001, 
Cohen’s d= 0.39) and GMCT scores did differ by sex (p=.004, Cohen’s d=-0.27) where females 
performed better on CPAL (fewer errors) and on GMCT (more moves per second). Older age was 
associated with worse performance on all CogState tests (p<.001, Pearson’s r’s = .165 to -.437) 
except ONB. Better GMCT performance correlated with more computer familiarity (p<.001, 
Spearman’s rho=.224), more years of education, (Pearson’s r=.138, p=.003), and better literacy 
(Pearson’s r=.192, p<.001). More errors on Groton Maze delayed recall was associated with a higher 
depression score (Pearson’s r=.138, p=.003). Higher accuracy on TWOB was correlated with better 
literacy (Pearson’s r=.159, p=.001). Effect sizes for all associations with demographic and CogState 
variables were small except between age and GMCT (Pearson’s r=-.437), which was moderate.  
 
The three non-CogState delayed memory scores did not significantly differ by APOE4 or family 
history, but females performed better on RAVLT delayed (p<.001, Cohen’s d=-0.81) and Logical 
Memory delayed (p=.005, Cohen’s d=-0.26). All three delayed recall scores were significantly 
correlated with age (Pearson’s r’s=.-.138 to -.239, p’s<.003), literacy (Pearson’s r’s=.194 to .324, 
p’s<.001), and education (Pearson’s r’s=.139 to .232, p’s<.003). Better performance on RAVLT 
delayed (Pearson’s r=.139, p=.003) and Logical Memory delayed (Pearson’s r=.150, p=.001) were 
also associated with more computer familiarity. A large effect size was observed for sex on RAVLT 
delayed and a moderate effect size was observed for literacy on Logical Memory delayed; all other 
effect sizes were small.  
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Because the majority of neuropsychological test scores and CogState scores were significantly 
correlated, only tests exceeding the threshold for a moderate association (correlation coefficient >.3) 
are reported in the text. A correlation matrix is also provided as Table 2 with moderate correlations 
in bold. CPAL correlated with RAVLT total (r=-.487), RAVLT delayed (r=-.478), BVMT total (r=-
.503), BVMT delayed (r=.476), and WMS-R Logical Memory delayed (r=-.335). GMCT correlated 
with RAVLT total (r=.332), RAVLT delayed (r=.305), Stroop (r=.412), TMT Part A (r=-.438), TMT 
Part B (r=-.420), BVMT total (r=.336), WMS-R Logical Memory immediate (r=.485), and Animal 
Naming (r=.366).  GML correlated with BVMT total (r=-.344) and delay (r=-.371). GMR correlated 
with BVMT total (r=-.324) and delay (r=-.335). OCL correlated with RAVLT delay (r=.311). 
TWOB correlated with TMT Part B (r=-.360) and WAIS-R Digit Symbol (r=.303).  
 
Table 2.  Pearson correlations between traditional neuropsychological tests and CogState 
Neuropsychological Test CPAL GMCT GML_ GMR OCL ONB TWOB
Memory 
RAVLT total trials 1-5 -.483** .331** -.265** -.285** .287** 0.087 .213** 
RAVLT delayed -.473** .302** -.252** -.264** .305** 0.091 .225** 
Logical Memory immediate -.294** .270** -.245** -.247** .167** 0.016 .183** 
Logical Memory delayed -.332** .274** -.279** -.280* .191** -0.007 .163** 
BVMT immediate -.500** .338** -.344** -.318** .272** 0.064 .278***
BVMT delayed -.474** .289** -.370** -.327** .237** .099 .283** 
Language 
Boston Naming -.191** .143* -.205** -.212** 0.082 0.009 .110 
CFL fluency -.113 .251** -0.047 -0.035 0.086 0.057 .115 
Animal Naming -.287** .368** -.198** -.194** .144* 0.019 .181** 
Executive function 
Stroop color-word interference -.211** .412** -.172** -.153* .198** .138* .293** 
TMT Part A .241** -.438** .227** .212** -.227** -.124* -.274** 
TMT Part B .328** -.421** .266** .248** -.292** -.142* -.355**
WAIS-R Digit Symbol -.238** .486** -.161** -.186** .167** .156* .301** 
WAIS-R Letter Number -.252** .234** -.204** -.188** .209** 0.086 .258** 
WAIS-R Digit Span Forward -.204** .172** -.165** -.113 .183** 0.08 .250** 
WAIS-R Digit Span Backward -.243** .182** -.238** -.256** .179** 0.068 .227** 
Global function        
MMSE -.132* .201** -.194** -.158* .211** .101 .165** 
Pearson correlation coefficients are reported. *r<.01; *r<.001. RAVLT= Rey Auditory Verbal 
Learning Test; BVMT= Brief Visuospatial Memory Test; TMT=Trail Making Test; WAIS-
R=Wechsler Adult Intelligence Scale-Revised; MMSE= Mini Mental State Exam; CPAL= 
Continuous Paired Associate Learning (CPAL); GMCT=Groton Maze timed chase test; GML= 
Groton Maze learning test; GMR=Groton Maze learning test delayed recall; OCL=One-card 
learning; ONB=One-back memory; TWOB=Two-back memory.  
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3.2 CogState performance by cognitive status  
 
After controlling for risk factors and demographics, CogState performance differed between 
individuals who are cognitively impaired and cognitively normal controls for all CogState tests 
(p<.007, Table 3, Figure 1) except ONB. All effect sizes were small except GMR, which was 
moderate. Predictably, the three delayed memory tests were also significantly different between the 
cognitive groups (p<.007); effect sizes were large for RAVLT delayed and moderate for Logical 
Memory delayed and BVMT delayed. This was an expected finding since the non-CogState memory 
tests were considered when making the diagnosis.  
 
There were several other significant (p<.05) predictors in the CogState models. Age and literacy 
were significant predictors of CogState performance in every model except ONB. Sex was a 
significant predictor for CPAL, GML, and GMR. APOE4 was a significant predictor of CPAL and 
GML. Computer familiarity was significantly associated with GMCT and family history was 
significantly associated with OCL.  
 
Table 3. CogState and traditional neuropsychological test performance by MCI status  
CogState Test Cognitively 
Impaired (n=70)
Cognitively 
Normal (n=393)
F p-value Partial eta-
squared 
CPAL errors 116.29 (53) 77.55 (50.3) 22.15 <.001 .048 
GMCT moves/sec 0.96 (.26) 1.16 (.22) 26.47 <.001 .055 
GML errors 62.72 (17) 51.75 (16.3) 18.19 <.001 .039 
GMR errors 11.68 (5.1) 8.17 (4.4) 30.38 <.001 .065 
OCL accuracy 0.97 (.09) 1.02 (.09) 9.58 .002 .021 
ONB accuracy 1.37 (.14) 1.39 (.13) 0.31 .576 .001 
TWOB accuracy  1.18 (.15) 1.27 (.13) 16.59 <.001 .036 
RAVLT delayed 7.47 (3.5) 11.32 (2.5) 104.04 <.001 .187 
Logical Memory delayed 20.63 (6.6) 27.63 (6.4) 55.26 <.001 .109 
BVMT delayed 8.57 (2.2) 10.21 (1.7) 39.76 <.001 .081 
CPAL= Continuous Paired Associate Learning; GMCT=Groton Maze timed chase test; GML= 
Groton Maze learning test; GMR=Groton Maze learning test delayed recall; OCL=One-card 
learning; ONB=One-back memory; TWOB=Two-back memory. RAVLT= Rey Auditory Verbal 
Learning Test; BVMT= Brief Visuospatial Memory Test. 
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Figure 1. Comparison of Cognitively Normal and Cognitively Impaired groups on mean 
performance on CogState tests. Error bars represent 95% confidence intervals.  
3.3 Association between CogState and Composite Cognitive Impairment Index 
 
VIF and tolerance were in the normal range for all models. CCII significantly predicted performance 
on all CogState tests examined (p<.007, Table 4, Figure 2). Age at CogState testing (CPAL, GMCT, 
GML, OCL, TWOB) and sex (GML, GMR, TWOB) were common additional predictors of 
CogState performance (p<.05). Computer familiarity also significantly predicted GMCT only 
(p<.05). Logical memory delayed and BVMT delayed also significantly predicted CCII (p<.007, 
Table 4). Effect sizes were moderate for CPAL, GMR, Logical Memory delayed, and BVMT 
delayed; all others were small.  
 
Table 4. CCII as a predictor of CogState performance 
CogState Test β-coefficient T p-value f2 R2 R2 change
CPAL errors 22.201 10.864 <.001 0.2644 .304 .184 
GMCT moves/sec -.041 -4.546 <.001 0.0459 .324 .031 
GML errors 4.823 6.835 <.001 0.0985 .198 .082 
GMR errors 1.765 9.045 <.001 0.1846 .209 .145 
OCL accuracy -.023 -5.515 <.001 0.0682 .135 .059 
ONB accuracy -.017 -2.730 .007 0.0690 .030 .017 
TWOB accuracy  -.039 -6.697 <.001 0.0996 .197 .080 
Logical Memory delayed -2.37 -8.798 <.001 0.1693 .291 .120 
BVMT delayed -.652 -8.769 <.001 0.1680 .256 .125 
CPAL= Continuous Paired Associate Learning; GMCT=Groton Maze timed chase test; GML= 
Groton Maze learning test; GMR=Groton Maze learning test delayed recall; OCL=One-card 
learning; ONB=One-back memory; TWOB=Two-back memory. RAVLT= Rey Auditory Verbal 
Learning Test; BVMT= Brief Visuospatial Memory Test. 
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Figure 2. Relationships between CogState tests and a Composite Cognitive Impairment Index 
estimated at age 65. 95% confidence intervals for the regression line are displayed. 
 
3.4 Biomarkers 
Overall, biomarkers were not strongly associated with CogState scores. CSF NFL was correlated 
with CPAL (Pearson’s r=.281, p=.022), GMCT (Pearson’s r=.-.293, p=.014), and GML (Pearson’s 
r=.261, p=.029). PiB burden (Pearson’s r=-.250, p=.019) and CSF t-tau/Aβ42 (Pearson’s r=-.265, 
=.029) were correlated with OCL. When the outlier was removed, the association between PiB 
burden and OCL became a trend (p=.060). Additional trends were observed between CSF t-
tau/Aβ42 and GMR (Pearson’s r=.229 p=.062); PiB positivity and GML (t=-.1842, p=.069); and 
PiB positivity and OCL (t=1.945, p=.055). When these correlations were investigated further in 
regression and ANCOVA models, CSF NFL, PiB burden, and PiB positivity were not predictive of 
CogState performance, but CSF t-tau/Aβ42 (Figure 3) was a significant predictor of OCL 
performance (β=-.057, t=-2.042, f2=.0724, R2=.144, R2-change=.063, p=.046).  
 
RAVLT delayed (Pearson’s R=-.378, p=.001), Logical Memory delayed (Pearson’s R=-.300, 
p=.012), and BVMT delayed (Pearson’s R=-.257, p=.031) all correlated with CSF NFL. However, 
none of these relationships were significant in regression models controlling for other factors. There 
was a trend for CSF NFL predicting Logical Memory delayed (β=-4.861, t=-1.902, p=.062).  
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Figure 3. Partial regression plot of natural log-transformed CSF t-tau/Aβ42 and One-card learning 
performance as measured by arcsine-corrected accuracy. 95% confidence intervals for the regression 
line are displayed.  
4 DISCUSSION 
 
Computer-based psychological batteries offer several advantages over traditional psychological 
(often paper-and-pencil-based) tests including reduced testing time and administrative training, 
standardization of test administration, accurate measures of response latencies, and reduced risk of 
human error (Snyder, et al., 2011; Wild, Howieson, Webbe, Seelye, & Kaye, 2008). Consequently, 
there has been a shift in interest to computer-administrated psychological batteries. CogState is one 
such computerized battery that has been shown to have good accuracy, efficiency, and stability for 
repeated assessment, as well as demonstrated sensitivity to cognitive impairment and cognitive 
change (Fredrickson, et al., 2010; Zygouris & Tsolaki, 2015). Here we evaluated CogState 
performance at a single time point in relation to traditional neuropsychological tests, cognitive 
status, and biomarkers in a late-middle-aged sample from the WRAP cohort. We sought to provide 
convergent and construct validity for CogState during the earliest stages of potential AD and to 
provide a context for comparing CogState to traditional gold-standard tests of delayed memory.  
 
Our results are consistent with previous studies of CogState showing weak to moderate relationships 
with demographic variables and traditional cognitive tests (Hammers, et al., 2012; Lim, et al., 2012; 
Mielke, Machulda, Hagen, Edwards, et al., 2015). Associations with demographic characteristics 
were generally small, with the most consistent relationships observed with age and sex. GMCT was 
most affected by demographic characteristics like computer familiarity, education, and literacy. 
Traditional delayed memory tests were much more strongly associated with demographic 
characteristics, supporting the theory that CogState is more robust to education level compared to 
traditional paper-based neuropsychological tests.  
4.1 Convergent validity 
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While the majority of CogState and paper-based tests were significantly correlated, only the 
correlation between CPAL and BVMT immediate—both tests of visual memory—passed the 
threshold for a large effect (r=-.5), but there were several other moderate associations. CPAL was 
also correlated with two tests of verbal memory, RAVLT and WMS-R Logical Memory. The Groton 
Maze tests combine skills of executive function, learning, and memory and correspondingly were 
correlated with traditional neuropsychological tests of memory (RAVLT, BVMT, WMS-R Logical 
Memory, Animal Naming) and executive function (Stroop, TMT). Interestingly, GMCT, which is 
generally considered a task to introduce subjects to the Groton Maze learning and delayed recall 
tasks, had the most associations with other neuropsychological tests of the three maze paradigms; 
GML and GMR were both only correlated with BVMT total and delay. Of the card tests, OCL, a 
visual memory test, was correlated with RAVLT delay; and TWOB, a test of working memory, was 
correlated with two executive functioning tasks, TMT Part B and WAIS-R Digit Symbol. 
Correlations between CogState and traditional neuropsychological tests, therefore, were generally 
consistent with the domains they are expected to probe.  
 
Curiously, although ONB is included in CogState’s Alzheimer’s Battery, it was the most weakly 
correlated with any traditional neuropsychological tests, often not reaching even liberal thresholds 
for statistical significance (i.e., p<.05). Performance on ONB was also the only CogState test that did 
not differ between cognitively normal and cognitively impaired groups. Given the relative health and 
youthfulness of our sample, we suspect this test was too easy for our participants and resulted in a 
marked ceiling effect. Indeed, participants only made on average two errors on ONB with one-
fourth of the sample making zero errors and 93% of participants making five or fewer errors. This 
contrasts with the other two card tasks: an average of five errors were made on TWOB with only 
7% making zero errors, and an average of 26 errors were made on OCL and no participants made 
fewer than 10 errors. Others have found differences between diagnostic groups on ONB test using 
reaction time instead of accuracy, which could be less prone to ceiling effects and may be more 
applicable in cohorts without clinical dementia (Mielke, Machulda, Hagen, Edwards, et al., 2015). Its 
major function in the battery we selected was to serve as a warm up test for the more difficult TWB 
task. Our results suggest that ONB accuracy is less useful in the age range of our sample.  
 
One of the earliest studies of CogState showed that patients with MCI declined within a one-year 
period on a CogState memory task (Continuous Learning Test) while decline was not detectable 
using routine memory tests (Maruff, et al., 2004). While we were not able to address decline in 
CogState performance across groups with only one time point for CogState, we did incorporate the 
extensive longitudinal data that has been collected in WRAP using traditional neuropsychological 
tests to create a composite of cognitive impairment. This type of cognitive impairment index could 
be a useful tool against which to measure novel tests of cognitive/clinical status and progression, 
like CogState. Both CogState and traditional delayed memory tests were associated with CCII. Effect 
sizes were moderate for CPAL, GMR, Logical Memory delayed, and BVMT delayed with the largest 
effect size observed for CPAL. Both GMR and CPAL test delayed recall using two different 
paradigms.  
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4.2 Convergent validity 
 
With the exception ONB, cognitively impaired individuals differed significantly in their performance 
on CogState tests compared to cognitively normal controls. The difference was generally small, with 
the most marked difference observed for GMR. While the traditional delayed memory tests were 
large or moderate, these tests were available to the clinicians determining the consensus diagnosis so 
this finding is not particularly informative. It is interesting that the only CogState test to also have a 
moderate effect was the GMR, pointing to the emphasis on dysfunction in delayed memory for a 
diagnosis of cognitive impairment.  
 
We did not find strong evidence for an association between CogState performance and biomarker 
levels with the exception of a mild relationship detected between higher levels of CSF total-
tau/Aβ42 and worse performance on OCL test, which uses a pattern separation paradigm to 
measure visual memory. Most previous studies that have found an association between biomarkers 
and CogState have evaluated intra-individual cognitive decline based on longitudinally acquired 
CogState testing rather than a single time point (Darby, et al., 2011; Lim, Ellis, et al., 2013; Lim, et 
al., 2014; Lim, Pietrzak, et al., 2015; Mielke, Machulda, Hagen, Christianson, et al., 2015). In 
contrast, a study with a single CogState evaluation did not find an association between CogState 
performance and amyloid PET (Mielke, et al., 2014). The latter study did, however, find relatively 
weak associations between CogState performance and FDG-PET hypometabolism and smaller 
hippocampal volumes, suggesting that a single time point could still be informative of underlying 
pathology. While we were able to detect a relationship between a CSF measure of co-occuring 
amyloid and tau pathology and one CogState test but none of the three traditional delayed memory 
tests, it remains unclear whether CogState at one time point would substantially improve inference 
about underling pathology beyond what is possible with traditional paper-based neuropsychological 
tests.  
 
4.3 Limitations 
 
The primary limitations of this study are that biomarkers were collected several years before 
CogState administration and that we do not yet have serial CogState testing, both of which constrain 
our ability to make stronger inferences about CogState and underlying pathology. Additionally, our 
study cohort was largely white and well educated, and so generalizability is restricted; it will be 
important to perform similar studies with CogState in more diverse populations. Longitudinal 
clinical outcomes will also be important for evaluating prognostic utility of CogState. 
 
4.4 Conclusions 
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Overall this study provided convergent and construct validity for the use of CogState in evaluating 
cognitive function during late-middle-age. However, it also suggests that CogState at a single time 
point may not substantially improve preclinical AD detection over traditional neuropsychological 
tests. Still, its administration offers several advantages over paper-based tests, which make it 
desirable for large, longitudinal studies with demographic variability. Future directions will focus on 
longitudinally collected CogState data in the WRAP cohort and examination of a greater array of 
biomarkers.  
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8 SUPPLEMENTARY MATERIAL 
 
 
 
Supplementary Figure 1. ROC Curve for PiB burden based on PiB visual ratings of positivity. Area 
under the curve=.974.  
